Company Description
Biodel delves into the development of viable treatments for endocrine disorders. The company uses its VIAdel biological technology to reformulate...
Key Biodel Financials
| Company Type | Public - NASDAQ (GM): BIOD Main Headquarters |
|---|---|
| Fiscal Year-End | September |
| Employees | -- |
More Biodel Financials (11 pages)
Latest Biodel Jobs jobs by Indeed
Competition
Competitive Landscape for Biotechnology Sector
The industry is marked by rapid advances in scientific knowledge that produce ever-more effective medicines. Profitability is determined mainly by the ability to discover new drugs. The industry is...
Read more about Biodel's competition across multiple industries
Top Biodel Competitors
Sponsored Links
The Business Directory
Biodel Executives
| Title | Name & Bio | Contact |
|---|---|---|
| VP Corporate Development, CFO, and Treasurer | Gerard J. (Gerry) Michel | Network | E-mail |
| Chairman, President, and CEO | Solomon S. Steiner | Network | E-mail |
| VP Operations | Erik Steiner | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Biodel News
- Biodel Announces Publications Demonstrating Superior Metabolic Profile of VIAject Compared to the Rapid-acting Analog Humalog and Regular Human... [Diabetes Week] (11 Aug 2008 00:01:00 EDT)
- Briefing.com: Hourly In Play (R) - 23:00 ET [Briefing.com] (07 Aug 2008 23:00:00 EDT)
- Briefing.com: Hourly In Play (R) - 22:00 ET [Briefing.com] (07 Aug 2008 22:00:00 EDT)
Sponsored Opportunity
